Compounds > 9,10-phenanthrenequinone
Page last updated: 2024-08-17

9,10-phenanthrenequinone and Lung Neoplasms

9,10-phenanthrenequinone has been researched along with Lung Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Kabbani, O; Endo, S; Haga, M; Hara, A; Ikari, A; Matsunaga, T; Morikawa, Y; Soda, M; Tajima, K; Yamamura, K1

Other Studies

1 other study(ies) available for 9,10-phenanthrenequinone and Lung Neoplasms

ArticleYear
Exposure to 9,10-phenanthrenequinone accelerates malignant progression of lung cancer cells through up-regulation of aldo-keto reductase 1B10.
    Toxicology and applied pharmacology, 2014, Jul-15, Volume: 278, Issue:2

    Topics: Aldehyde Reductase; Aldo-Keto Reductases; Cell Line, Tumor; Disease Progression; HEK293 Cells; Humans; Lung Neoplasms; Phenanthrenes; Up-Regulation

2014